Effects of acetazolamide in patients with the sleep apnoea syndrome.
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
There is as yet no convincing evidence that acetazolamide, a carbonic anhydrase inhibitor, is effective in obstructive sleep apnoea. A study was therefore designed to examine the effect of acetazolamide (250 mg/day) on sleep events and ventilatory control during wakefulness in nine patients with the sleep apnoea syndrome. In eight of the nine patients the apnoea index and the total duration of apnoea were reduced by acetazolamide, and the mean (SEM) apnoea index of all patients changed from 25.0 (6.7) to 18.1 (5.8) episodes an hour. Furthermore, the total time of arterial oxygen desaturation (SaO2)--more than 4% depression in SaO2 from the baseline sleeping level--divided by total sleep time was also significantly decreased and its mean (SEM) value improved from 24.1 (7.9) to 13.6 (4.8)% of total sleep time. Five of the seven patients with varying degrees of daytime hypersomnolence had their symptoms obviously improved. There was no patient whose predominant type of apnoea was converted from the obstructive to the central type, or vice versa. In the studies of wakefulness, metabolic acidosis, an increase of arterial oxygen tension (PaO2) and a decrease of arterial carbon dioxide tension (PaCO2) were observed. The slopes of the occlusion pressure response and the ventilatory response to carbon dioxide increased, and the carbon dioxide ventilatory response line shifted to the left. It is suggested that acetazolamide cannot remove apnoea completely but has a beneficial effect in mild cases of obstructive sleep apnoea through an augmentation of central (CO2, H+) drive and a stabilising effect on ventilatory control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protriptyline in Obstructive Sleep Apnea: A Double-Blind Trial
Brownell, L. G., West, P., Sweatman, P., Acres, J. C., & Kryger, M. H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198210213071701 · Cited by 233
Cited by
Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
Lv, R., Liu, X., Zhang, Y., Dong, N., Wang, X., He, Y., Yue, H., & Yin, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01496-3 · Cited by 477
Obesity hypoventilation syndrome
Masa, J. F., Pépin, J.-L., Borel, J.-C., Mokhlesi, B., Murphy, P. B., & Sánchez-Quiroga, M. Á. (2019) · European Respiratory Review · doi:10.1183/16000617.0097-2018 · Cited by 360
Obesity Hypoventilation Syndrome: A State-of-the-Art Review
Mokhlesi, B. (2010) · Respiratory Care · doi:10.4187/respcare.10551347 · Cited by 340
Edwards, B. A., Sands, S. A., Eckert, D. J., White, D. P., Butler, J. P., Owens, R. L., Malhotra, A., & Wellman, A. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.223925 · Cited by 298
“Conversely, the only study conducted in OSA subjects suggests acetazolamide increases CO2 sensitivity, which would tend to raise LG (Tojima et al. 1988).”
BackgroundA method for measuring and modeling the physiological traits causing obstructive sleep apnea
Wellman, A., Eckert, D. J., Jordan, A. S., Edwards, B. A., Passaglia, C. L., Jackson, A. C., Gautam, S., Owens, R. L., Malhotra, A., & White, D. P. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00972.2010 · Cited by 283
Metadata
- Authors
- Tojima, H., Kunitomo, F., Kimura, H., Tatsumi, K., Kuriyama, T., & Honda, Y.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 1988-02-01
- Volume
- 43
- Issue
- 2
- Pages
- 113-119
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2123601530
- Cited by
- 102
- References
- 1
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.